This Delhi XIX Commonwealth Games are now over. This Website is closed and for reference purposes only and some of the external links may no longer work.

The Delhi XIX Commonwealth Games are now over. This website is closed and for reference purposes only. Some external links may no longer work.For the latest news and information, please visit the Commonwealth Games Federation website.

The objective of the Commonwealth Games Federation Anti Doping Standard (CGF-ADS) is to provide an understanding of anti-doping rules, regulations and specific technical procedures and policies, enacted and applicable exclusively for the XIX Commonwealth Games 2010 Delhi, addressed to all athletes and officials of each Commonwealth Games Association participating in Delhi 2010.

The CGF-ADS describes the roles and responsibilities of the organisations as well as individuals involved in the Doping Control Programme developed for the XIX Commonwealth Games 2010 Delhi. It also provides an overview of the Commonwealth Games Federation Doping Control Programme enacted in collaboration with the Doping Control Division of the Organising Committee Commonwealth Games 2010 Delhi exclusively for the XIX Commonwealth Games 2010 Delhi.

The CGF- ADS will apply to all athletes participating in Delhi 2010, i.e., able bodied athletes, para-athletes and support personnel.

The Doping Control Programme at the XIX Commonwealth Games 2010 Delhi has been set up in concert with the Commonwealth Games Federation (CGF), which will be the Anti-Doping Organisation from 23 September 2010 to 14 October 2010.

The CGF Medical Commission, under the chairmanship of Dr. M. Jegathesan, will authorise the selection of athletes, supervise sample collection procedures and review adverse and unusual analytical findings and other anti-doping rule violations. The CGF Medical Commission is the final authority on the Doping Control Programme developed by the Doping Control Division for Delhi 2010. The members of the CGF Medical Commission for Delhi 2010 are:

• Dr. M. Jegathesan (Malaysia), Chairman

• Dr. Brian Sando (Australia), Member

• Dr. Herb Elliott (Jamaica), Member

• Ms. Michele Verroken, Member/Secretary

• Prof. Ken Fitch (Australia), Member and Chair of the TUE Committee;

• Dr. Andrew Pipe (Canada), Member

• Dr. Harold Adams (South Africa), Member

• Dr. Brian Walker (Scotland), Member

• Prof. Manmohan Singh (India), Member.

The CGF Medical Commission will conduct an initial review of any adverse analytical findings and other potential anti-doping rule violations. The CGF Medical Commission may also delegate its powers to investigate other potential anti- doping rule violations. Following an initial review or investigation, the CGF Medical Commission will refer potential anti-doping rule violations to the CGF Court.

The CGF Medical Commission has established a Therapeutic Use Exemption (TUE) Committee to acknowledge the receipt of notifications of TUEs from athletes ahead of the Games.

The CGF TUE Committee will also process applications of TUEs from athletes who have not obtained a TUE from their respective International Federation or national anti-doping organisation. The following members constitute the CGF TUE Committee for Delhi 2010: